ATLASATLAS fair value
SEK 125.68
Close to fair value · 2% discount
Range: SEK 84–SEK 181Fair valuePrice
BioGaia AB (publ) (BIOG-B.ST)
BioGaia AB (publ) stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Nasdaq Stockholm · Sweden
SEK 123.80▼ -0.56%
Prices as of Oct 27, 2026 · SEK
Chance of rising in 1 month
53%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on BioGaia AB (publ) in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On BioGaia AB (publ)
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates BioGaia AB (publ)'s fair value at about SEK 125.68 per share (reasonable range: SEK 84.37 to SEK 181.25). At SEK 123.80, the stock trades within 8% of that figure: close to fair value.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is high. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives BioGaia AB (publ) a 53% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 119.42 and SEK 129.28; in 9 out of 10, between SEK 111.31 and SEK 138.69. Estimated annual volatility is 21%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 12.3B
- Market cap (USD)
- $1.2B
- P/E ratio
- 32.8
- Dividend yield
- 1.27%
- 52-week high
- SEK 136.30
- 52-week low
- SEK 96.20
- Revenue (12 months)
- SEK 1.7B
- Gross margin
- 72.7%
- Operating margin
- 33.1%
- Net margin
- 23.7%
- Beta
- 0.27
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. BioGaia AB (publ) sits close to fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks BIOG-B.ST has traded between SEK 96.20 and SEK 136.30. Today it is 9.2% below that high and 29% above its low.
On the business: net margin is 23.7%; it trades at 32.8 times earnings.
Its beta is 0.27: it tends to move less than the market.
About the company
BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand.
Want to see everything about BioGaia AB (publ)?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is BioGaia AB (publ) (BIOG-B.ST) fair value?
About SEK 125.68 per share according to ATLAS (reasonable range: SEK 84.37 to SEK 181.25). With the stock at SEK 123.80, it is close to that value.
What is the chance BIOG-B.ST goes up next month?
53%: close to a coin flip. In half of the simulated outcomes, BIOG-B.ST ends the month between SEK 119.42 and SEK 129.28.
How big is BioGaia AB (publ) and what is its P/E ratio?
BioGaia AB (publ)'s market capitalization is SEK 12.3B. Its price-to-earnings (P/E) ratio is 32.8: you pay SEK 32.8 for each SEK 1.00 of yearly earnings.
Does BioGaia AB (publ) pay a dividend?
Yes. BIOG-B.ST's current dividend yield is 1.27% at today's price (SEK 123.80).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer